Article Text
Abstract
Point-of-care evidence-based medicine websites allow physicians to answer clinical queries using recent evidence at the bedside. Despite significant research into the function, usability and effectiveness of these programmes, little attention has been paid to their ethical issues. As many of these sites summarise the literature and provide recommendations, we sought to assess the role of conflicts of interest in two widely used websites: UpToDate and Dynamed. We recorded all conflicts of interest for six articles detailing treatment for the following conditions: erectile dysfunction, fibromyalgia, hypogonadism, psoriasis, rheumatoid arthritis and Crohn's disease. These diseases were chosen as their medical management is either controversial, or they are treated using biological drugs which are mostly available by brand name only. Thus, we hypothesised that the role of conflict of interest would be more significant in these conditions than in an illness treated with generic medications or by strict guidelines. All articles from the UpToDate articles demonstrated a conflict of interest. At times, the editor and author would have a financial relationship with a company whose drug was mentioned within the article. This is in contrast with articles on the Dynamed website, in which no author or editor had a documented conflict. We offer recommendations regarding the role of conflict of interest disclosure in these point-of-care evidence-based medicine websites.
- Codes of/Position Statements on Professional Ethics
- Information Technology
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Conflict of interest policies and disclosure requirements among European Society of Cardiology national cardiovascular journals
- Vaginal mesh implants: putting the relations between UK doctors and industry in plain sight
- Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
- WHO and the pandemic flu “conspiracies”
- Conflict of interest between professional medical societies and industry: a cross-sectional study of Italian medical societies’ websites
- Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn’s disease: a pooled analysis of 11 317 patients across clinical trials
- Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study
- Pharmaceutical payments to certified oncology specialists in Japan in 2016: a retrospective observational cross-sectional analysis
- Ethical concerns with online direct-to-consumer pharmaceutical companies
- Content analysis of Twitter in relation to biological treatments for chronic inflammatory arthropathies: an exploratory study